Transduction P y y n/d
213 Map Kinase Phosphatase-1 (MKP-1) M3787 Signal Transduction P y n/d n/d
214 Protein phosphatase 1α P7979 Signal Transduction P y n/d n/d
215 PTEN P7482 Signal Transduction P
of fresh and cryopreserved
human peripheral blood mononuclear cells.
J Immunol Methods 1998; 214: 175-186
2. Boutonnat J,Muirhead K, Barbier M,
Mousseau M, Ronot X, Seigneurin D:
The use
margin to UC SCC358
ht-213-D 36 F Duodenum Normal margin to UC SCC359
ht-214-I 46 M Ileum Normal margin to UC SCC360
ht-214-I-J 46 M Ileum J-pouch Normal margin to UC SCC361
ht-227-D 62 M Duodenum Normal
). Specificity test shows ≥ 50% inhibition, in the
presence of 10 µM ATP and inhibitor, against 9 of 214 non-PAK human kinases. Shown
to effectively suppress both basal and PDGF-induced PAK activation
II. Suitable for the
dephosphorylation of phosphotyrosine residues in substrate proteins.
20 µg 214
Protein Tyrosine
Phosphatase PRL-3,
GST-Fusion, Human,
Recombinant, E. coli
539807 The catalytic
reagent grade water to
100% acetonitrile. Detection was performed
using UV detectors at 214 nm and 254 nm.
Ion Chromatography (IC)
IC was used to identify and quantify small organic
enzyme that
will hydrolyze 1.0 nmol of pNPP per minute at 30°C. M.W. 60,300
Cat. No. 535857 20 mg € 214
Ref.: Huynh, H., et al. 2003. J. Immunol. 171, 6661; Qi, Y., et al. 2002. J. Cell Biochem. 86
22 III (FL) 3x400/50/22 59 x 76 x 116 195 9 352 790 FP90-SL
0.4-0.7 0.2-0.4 22-26 M16x1 8 / 12 mm 28 x 23 / 22 22 III (FL) 3x400/50/22 59 x 76 x 116 188 9 352
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
www.ncbi.nlm.nih.gov/
books/NBK55878/ (accessed Sep 19, 2016).
(8) Schoental, R. Nature 1960, 188, 420.
(9) Lewis, C. E. J. Occup. Med. 1964, 6, 91.
(10) Arndt, F. In Organic Syntheses; Wiley: New York
100887 Ethyl 4-hydroxybenzoate, suitable for use as excipient
EMPROVE® exp Ph Eur, BP, JP, NF, E 214
EXP • • • • •
100864 Ethyl acetate, suitable for use as excipient
EMPROVE® exp